Houte Hans Van - Net Worth and Insider Trading
Houte Hans Van Net Worth
The estimated net worth of Houte Hans Van is at least $668,747 dollars as of 2024-12-26. Houte Hans Van is the CFO of Nurix Therapeutics Inc and owns about 33,724 shares of Nurix Therapeutics Inc (NRIX) stock worth over $668,747. Details can be seen in Houte Hans Van's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Houte Hans Van has not made any transactions after 2024-11-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Houte Hans Van
Houte Hans Van Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Houte Hans Van owns 1 companies in total, including Nurix Therapeutics Inc (NRIX) .
Click here to see the complete history of Houte Hans Van’s form 4 insider trades.
Insider Ownership Summary of Houte Hans Van
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NRIX | Nurix Therapeutics Inc | 2024-11-01 | Chief Financial Officer |
Houte Hans Van Latest Holdings Summary
Houte Hans Van currently owns a total of 1 stock. Houte Hans Van owns 33,724 shares of Nurix Therapeutics Inc (NRIX) as of November 1, 2024, with a value of $668,747.
Latest Holdings of Houte Hans Van
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NRIX | Nurix Therapeutics Inc | 2024-11-01 | 33,724 | 19.83 | 668,747 |
Holding Weightings of Houte Hans Van
Houte Hans Van Form 4 Trading Tracker
According to the SEC Form 4 filings, Houte Hans Van has made a total of 22 transactions in Nurix Therapeutics Inc (NRIX) over the past 5 years, including 0 buys and 22 sells. The most-recent trade in Nurix Therapeutics Inc is the sale of 3,546 shares on November 1, 2024, which brought Houte Hans Van around $86,097.
Insider Trading History of Houte Hans Van
- 1
Houte Hans Van Trading Performance
Houte Hans Van Ownership Network
Houte Hans Van Owned Company Details
What does Nurix Therapeutics Inc do?
Who are the key executives at Nurix Therapeutics Inc?
Houte Hans Van is the Chief Financial Officer of Nurix Therapeutics Inc. Other key executives at Nurix Therapeutics Inc include General Counsel Christine Ring , Chief Scientific Officer Gwenn Hansen , and EVP and COO Stefani Wolff .
Nurix Therapeutics Inc (NRIX) Insider Trades Summary
Over the past 18 months, Houte Hans Van made 14 insider transaction in Nurix Therapeutics Inc (NRIX) with a net sale of 82,022. Other recent insider transactions involving Nurix Therapeutics Inc (NRIX) include a net sale of 73,087 shares made by Christine Ring , a net sale of 14,703 shares made by Gwenn Hansen ,
In summary, during the past 3 months, insiders sold 37,393 shares of Nurix Therapeutics Inc (NRIX) in total and bought 0 shares, with a net sale of 37,393 shares. During the past 18 months, 169,812 shares of Nurix Therapeutics Inc (NRIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 169,812 shares.
Nurix Therapeutics Inc (NRIX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nurix Therapeutics Inc Insider Transactions
Houte Hans Van Mailing Address
Above is the net worth, insider trading, and ownership report for Houte Hans Van. You might contact Houte Hans Van via mailing address: C/o Nurix Therapeutics, Inc., 1700 Owens Street, Suite 205, San Francisco Ca 94158.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
